News
Dr. Sandra Demaria | Newsroom
news.weill.cornell.edu
Dr. Sandra Demaria. Without rigorous research to determine how best to use these treatments, the medical community "may fail to truly exploit the emerging new paradigms, which could impair further development of the field," the investigators write in the commentary, published June 14 in Trends in Cancer. "We need to strike a synergy between radiation and immunotherapy," said Dr. …
Radiation Oncology and Meyer Cancer Center - Special Seminar - Weill...
events.weill.cornell.edu
"Resetting the tumor immunologic phenotype with radiation" Presented by: Sandra Demaria, M.D. Professor of Pathology and Radiation Oncology NYU School of Medicine ...
2019 Lytix Biopharma - News Detail - Lytix Biopharmawww.lytixbiopharma.com/.../Lytix-Biopharma-supports-research-at-Weill-Cornell-Me...
www.lytixbiopharma.com
Dr. Sandra Demaria and her team at Weill Cornell Medicine, NY, will investigate the effect of LTX-315 in combination with irradiation on primary tumor and lung ...
News | Radiation Oncology
radiationoncology.weillcornell.org
differences between speakers, but some speakers were very engaging and
making their presentations amenable. Outstanding; Sandra Demaria put together
an excellent program of speakers; Some lectures could benefit from either more
time ...
sorted by relevance / date